NJHA Charts Rise and Fall of COVID Hospitalizations; Peak Occurred April 14

NJHA: A new bulletin from the New Jersey Hospital Association reviews the “rise and fall” of COVID-19 in New Jersey hospitals, charting the peak day of hospital activity on April 14 and the steady decline that is bringing the state’s hospitals close to pre-COVID capacity levels.

New Jersey reported its first COVID-19 case on March 4. The rapid rise of the virus in New Jersey culminated on April 14, when the state’s hospitals experienced the following peaks:

  • 8,084 patients were hospitalized with COVID-19
  • 82 percent of intensive care beds were filled
  • 62 percent of ventilators were in use.

These numbers represent a statewide average. However, COVID-19 activity varied significantly across regions of the state, with some facilities in northern New Jersey near 100 percent of capacity in mid-April.

The bulletin includes data through May 20, when 3,208 patients were hospitalized with COVID-19. That’s a 60 percent decline from hospitals’ peak.

“One of the greatest fears – that COVID cases would exceed our available beds and ventilators – never materialized, thanks to hospitals’ nimbleness in expanding capacity in our healthcare system,” said NJHA President and CEO Cathy Bennett. “It’s heartening to see the decline of COVID patients in our hospitals. We remain ever vigilant to not only protect New Jerseyans today, but also to build up our ability to respond to any signs of renewed virus activity.”

Other data in the review from NJHA’s Center for Health Analytics, Research and Transformation, captured through May 20, shows:

  • 150,339 N.J. residents have tested positive for the virus, which represents 1.7 percent of the state’s population. Nationally, more than 1.5 million have been infected, which represents approximately 0.45 percent of the population.
  • 10,747 N.J. residents have died from COVID-19, representing 7.1 percent of the state’s total COVID cases. Across the country, more than 90,000 individuals have died, for a national death rate at just over 6 percent.

Go to www.njha.com/CHART to view the full CHART bulletin.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy